Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ELTX
#4231
Elicio Therapeutics, Inc. - Common Stock
2.9
6
USD
-0.05%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-4.82%
Monthly Change
-27.09%
6 month change
-62.15%
Year Change
-70.40%
Previous Close
3.1
1
Open
2.9
4
Low
2.9
3
High
3.0
0
Volume
132
Markets
US Stock Market
Healthcare
Biotechnology
ELTX
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Q1, 26
TTM
Cash from operating activities
-10.12 M
-8.95 M
-11.09 M
-6.8 M
-11.64 M
-38.48 M
Cash from investing activities
0
0
0
-16 K
—
—
Cash from financing activities
10.33 M
11.93 M
9.57 M
4.86 M
8.03 M
34.39 M
Free cash flow
-10.12 M
-8.95 M
-11.09 M
-6.8 M
-11.64 M
-38.48 M
News
This Monthly Dividend Powerhouse Is Trading at a Bargain-Bin Valuation
Stocks Settle Sharply Higher as US-Iran Peace Deal Spurs Optimism
Stocks Rally as US-Iran Peace Deal Sinks Oil and Bond Yields
Stocks Soar on US-Iran Peace Agreement
Elicio Therapeutics: Hoping To Capitalize On Massive KRAS Hype, But Time Is Running Out
Is Aura Biosciences (AURA) Outperforming Other Medical Stocks This Year?
H.C. Wainwright raises Elicio Therapeutics price target to $17
Rodman & Renshaw initiates Elicio Therapeutics stock with buy rating
Is Quest Diagnostics (DGX) Stock Outpacing Its Medical Peers This Year?
Elicio Therapeutics (ELTX) Upgraded to Buy: Here's Why
Elicio reports antigen spreading in 87% of evaluated cancer patients
Elicio Therapeutics appoints Marc Wolfgang as chief technology officer